Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: Current status and challenges
Authors:
- 1 February 2018
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 126, 145-161
Abstract
No abstract availableKeywords
Funding Information
- Hong Kong General Research Fund (GRF16322016)
- Science and Technology Plan of Shenzhen (JCY20170818114038319)
This publication has 168 references indexed in Scilit:
- Simulating Intravitreal Injections in Anatomically Accurate Models for Rabbit, Monkey, and Human EyesPharmaceutical Research, 2012
- RNA-Based Therapeutics: Current Progress and Future ProspectsChemistry & Biology, 2012
- Comparison of Long-Acting Bevacizumab Formulations in the Treatment of Choroidal Neovascularization in a Rat ModelJournal of Ocular Pharmacology and Therapeutics, 2011
- Animal models of choroidal and retinal neovascularizationProgress in Retinal and Eye Research, 2010
- Simulating Dissolution of Intravitreal Triamcinolone Acetonide Suspensions in an Anatomically Accurate Rabbit Eye ModelPharmaceutical Research, 2010
- Subcellular targeting strategies for drug design and deliveryNature Reviews Drug Discovery, 2010
- A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matricesBiomaterials, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008
- Long-term Evaluation of AAV-Mediated sFlt-1 Gene Therapy for Ocular Neovascularization in Mice and MonkeysMolecular Therapy, 2005